As the patents on diabetes and anti-obesity drug semaglutide expire, at least 10 Indian pharmaceutical companies are preparing to conduct clinical trials for generic versions.

India aims to file 1,000 patents in critical minerals by 2030–31 under the National Critical Mineral Mission (NCMM) to boost self-reliance and strengthen its role in the global clean energy supply ...

Vinfast has filed a design patent in India for the Limo Green 7-seater electric MPV, hinting at a possible launch alongside ...

Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...

Financial reports from Nintendo's suppliers indicate the company is focused on getting more Switch 2 consoles ready for the ...

In the world of science and technology, we like to believe that the best ideas rise to the top. That innovation is a ...

The news digest highlights U.S. domestic affairs including Treasury Secretary Bessent's search for a new Fed Chair, the FDA resolving saline shortages, and Trump administration's scrutiny of Harvard's ...

After losing nearly $3 billion in research funding, Harvard University now risks losing control of its intellectual property ...

In a letter sent to Harvard President Alan M. Garber on Friday, Commerce Secretary Howard Lutnick alleges the university ...

The Trump administration on Friday launched an investigation into Harvard’s patents derived from federally funded research, ...

Here's why these three Motley Fool contributors think WM ( WM 0.81%), International Business Machines ( IBM -2.70%), and ...

The move is the latest escalation in the White House’s battle with the Ivy League school.